Physician profile
James B Harrell
NPI 1487682258
$1,229.11
in general payments reported to CMS, 2019-2025
16 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $99.68 · 2021: $100 · 2022: $193 · 2023: $259 · 2024: $278 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682 · Long Term Medical Supply Or Device Loan: $51.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.72 |
| Long Term Medical Supply Or Device Loan | $51.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $213.62 | 2023-2025 | Azstarys |
| Sanofi Pasteur INC. | $175.61 | 2019-2025 | |
| Glaxosmithkline, LLC. | $155.50 | 2019-2025 | Bexsero, Penmenvy |
| Pfizer INC. | $127.60 | 2020-2024 | |
| Genzyme Corporation | $121.87 | 2022 | |
| Merck Sharp & Dohme LLC | $102.34 | 2022-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Seqirus USA INC | $83.36 | 2024-2025 | Flucelvax |
| Baxter Healthcare | $51.82 | 2023 | Hillrom - Cp 150 Resting Electrocardiograph |
| Sanofi-Aventis U.S. LLC | $43.61 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.18 | 2020-2021 | |
| Genentech USA, INC. | $36.86 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $19.21 | 2021 | |
| Dermira, INC. | $17.18 | 2019 | |
| Supernus Pharmaceuticals, INC. | $16.29 | 2025 | Qelbree |
| Abbott Laboratories | $14.43 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Harrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.